Illumina Acquires Myraqa, a Leading IVD and Companion Diagnostic Consulting Firm Acquisition Strengthens Illumina’s Clinical Readiness SAN DIEGO–(BUSINESS WIRE)–Jul. 16, 2014– Illumina, Inc. (NASDAQ:ILMN) today announced that it has acquired Myraqa, a regulatory and quality consulting firm specializing in IVDs, ...
Read More »